SHANGHAI , April 8, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Denosumab Injection (trade name: MAIWEIJIAN, R&D code: 9MW0321) developed by its ...
JANESVILLE, Wis. , April 8, 2024 /PRNewswire/ -- SHINE Technologies, LLC (SHINE), a pioneer in next-generation fusion-based technology, becomes North America's largest producer of non-carrier added lutetium-177 (n.c.a. Lu-177) chloride, ...
SHANGHAI and NANJING , CHINA , and SAN JOSE, Calif. , April 4, 2024 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell ...
Compound 11c (GM-60106) , a novel 5HT 2A antagonist, paves the way for advancing metabolic liver disease treatment. GWANGJU, South Korea , April 4, 2024 /PRNewswire/ -- Metabolic dysfunction-associated steatotic liver disease ...
- Funding secured from CF Foundation and current investors for SPL84 Phase 2 study - - Two additional early-stage candidates expected to commence Phase 1-2a studies over the next 12 months – JERUSALEM , April 3, 2024 ...
YANTAI, China , April 2, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, obtained Fast Track Designation (FTD) by the United States Food and Drug ...
PITTSBURGH , April 1, 2024 /PRNewswire/ -- PANTHERx®Rare, a leader in rare disease product patient access and support services in the United States , is pleased to announce that it was selected by Edenbridge Pharmaceuticals for the ...
Full Data Readout Expected in the Second Half of 2024 CAMBRIDGE, Mass. , April 1 , 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming ...
FRISCO, Texas , March 29, 2024 /PRNewswire/ -- Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China and the United States , today ...
Phase 2 study is underway and LB-P8 is the only live biotherapeutic product currently reported to be in clinical development for the treatment of PSC FDA's Fast Track designation for LB-P8 underlines the urgent need for treatment options to ...
Generic drugs and Branded drugs are essentially the same, as they both have the same active ingredient. Generic drugs can provide the same therapeutic advantages as branded drugs at a reduced cost, as they do not have to undergo extensive ...
Melanoma is an extremely fatal form of skin cancer and has inherent resistance to both radiotherapy and chemotherapy ( ). The occurrence of Melanoma has been increasing steadily and become a major health issue since the 5-year ...
Using marijuana to alleviate nausea and vomiting during pregnancy could harm newborns’ brain development and exacerbate maternal health issues ...
A comprehensive study reveals that the use of antibiotics offers no significant improvement in the severity or duration of coughs , even in cases where a bacterial infection is detected. ...
Researchers have discovered no substantiated evidence indicating a causal relationship between acetaminophen usage during pregnancy and heightened risks of autism, ADHD, or intellectual disability in offspring...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers